A recent study by the Lancet highlighted the decreasing fertility rate globally as well as in India. The findings of the study revealed that from 1950 to 2021, the total fertility rate globally decreased by nearly 50% and in India, it decreased by more than 70%1. The rise in fertility issues is caused by a combination of factors such as shifts in marital timelines, lifestyle changes, medical conditions such as polycystic ovary syndrome and endometriosis, and the prevalence of factors detrimental to fertility, such as obesity, stress, smoking, and pollution.
Advancements in the healthcare sector have led to the establishment of a flourishing fertility industry in India with Assisted Reproductive Technologies (“ART”) such as In-Vitro Fertilisation (“IVF”) being one of the most sought-after treatments for fertility issues. This note analyses the IVF sector in India and the regulatory framework surrounding it.
The Indian IVF industry is one of the fastest-growing sectors globally, with over 2,500 fertility clinics across the country and an impressive CAGR of 16.5% from 2023 to 2030.2 State-of-the-art medical infrastructure and cost-effective services are the key drivers of the Indian IVF industry. The industry has seen an increase in several strategic investments in key players such as Indira IVF, Nova IVF and Ferty9 Fertility Centre. Approximately 2 million patients from around 76 countries visit India for medical, wellness, and IVF treatments, generating $6 billion for the industry, which is expected to increase to $13 billion by 2026.3
The first IVF baby in India was born in 1978, but for decades, there was no regulatory framework governing IVF and the IVF service providers. With no proper legal mechanisms in place, unethical actions such as DNA mismatches, unethical sourcing, and use of gametes, sex determination, etc. went unchecked.
The first measures undertaken to regulate IVF in India were through the National Guidelines for Accreditation, Supervision and Regulation of ART Clinics in India, 2005. These guidelines provided for the registration of IVF clinics, the code of practice, the responsibilities of medical practitioners, the basic infrastructure required in the IVF facilities. However, the guidelines did not define any penalty for non-compliance and leaving several healthcare professionals could not be held accountable for lapses that were committed.
Recognising the need to regulate ART in India, the Assisted Reproductive Technology (Regulation) Act, 2021 (“Act”) and the corresponding Assisted Reproductive Technology (Regulation) Rules, 2022 (“Rules”) were introduced. The Act established regulatory authorities at the national and state levels to ensure the implementation of the legal framework.
The landscape of IVF procedures and the corresponding industry in India has evolved significantly in the last decade. There has been an upswing in awareness about IVF in India through various channels. The introduction and implementation of the legal framework have fostered greater transparency and ensured patient safety. This has contributed to the overall growth and reliability of the IVF industry in India which makes it a booming industry for private investments. The combination of heightened awareness and improved governance is shaping a more promising future for the IVF industry.
[1] Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021, Lancet, https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)00550-6/fulltext#seccestitle170
[2] https://www.expresshealthcare.in/news/indias-fertility-sector-a-promising-avenue-for-investment-and-growth/440262/
[3]https://www.thehindubusinessline.com/news/after-being-a-pharma-hub-india-is-now-a-medical-tourism-destination-finance-minister/article66301970.ece
[4]Section 2(n), Assisted Reproductive Technology (Regulation) Act 2021
[5]Section 27, Assisted Reproductive Technology (Regulation) Act 2021.
[6]Section 33(2), Assisted Reproductive Technology (Regulation) Act 2021.
[7]Section 37, Assisted Reproductive Technology (Regulation) Act 2021.
This website is owned and operated by Spice Route Legal, and is exclusively meant to be a source of information on the firm, it’s practice areas, and its members.
It is not intended and should not be construed as any form of advertisement, solicitation, invitation or inducement of any sort from the firm or its members.
Spice Route Legal does not warrant that any information provided on the website is accurate, complete or updated, and further denies liability for any and all loss or damage caused to the user as a result of their reliance on the content provided.
The information made available on this site must in no way be relied upon, or construed, as legal advice. If you need legal assistance, we recommend you seek help from competent counsel licensed to practice and advise in the relevant jurisdiction.